Back to Search Start Over

Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma

Authors :
Croucher, PI
Hijzen, A
Shipman, CM
Perry, M
Lippitt, J
Green, J
Van Camp, B
Vanderkerken, K
Immunology and Microbiology
Vrije Universiteit Brussel
Publication Year :
2016

Details

Database :
OpenAIRE
Accession number :
edsair.dedup.wf.001..c81d3fa006102c471d45720bdd565537

Tools

Authors Abstract Subjects Details